XML 47 R36.htm IDEA: XBRL DOCUMENT v3.25.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2024
INCOME TAXES  
Schedule of income tax expense benefit

 

 

For the Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Current:

 

 

 

 

 

 

Federal

 

$-

 

 

$-

 

State

 

 

-

 

 

 

-

 

Foreign

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

Federal

 

 

-

 

 

 

-

 

State

 

 

-

 

 

 

-

 

Foreign

 

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

Total

 

$-

 

 

$-

 

Schedule of net income (loss) before income tax

 

 

For the Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

United States

 

$(4,476,762)

 

$(3,402,592)

Foreign

 

 

-

 

 

 

-

 

Total

 

$(4,476,762)

 

$(3,402,592)
Schedule of effective income tax rate reconciliation

 

 

For the Year Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

Income (Loss) before income tax

 

$(4,476,762)

 

$(3,402,592)

US statutory corporate income tax rate

 

 

28%

 

 

28%

Income tax expense computed at US statutory corporate income tax rate

 

 

(1,253,493)

 

 

(952,726)

Reconciling items:

 

 

 

 

 

 

 

 

Change in valuation allowance on deferred tax assets

 

 

1,152,938

 

 

 

2,121,778

 

Provision to prior year tax return

 

 

68,437

 

 

 

(1,188,884)

Meals and Entertainment

 

 

2,330

 

 

 

3,347

 

Other

 

 

29,788

 

 

 

16,485

 

Income tax expense (benefit)

 

$-

 

 

$-

 

Schedule of deferred income tax assets (liabilities)

 

 

December 31,

 

 

December 31,

 

 

 

2024

 

 

2023

 

Deferred tax assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

Reserve for Credit Loss

 

$624,000

 

 

$418,000

 

Inventory Reserve

 

 

308,000

 

 

 

27,000

 

Accrued Vacation

 

 

78,000

 

 

 

53,000

 

Warranty Reserve

 

 

8,000

 

 

 

8,000

 

Intangible Assets

 

 

98,000

 

 

 

181,000

 

Allowance for Sales Returns

 

 

64,000

 

 

 

-

 

Capitalized R&D

 

 

175,000

 

 

 

148,000

 

Stock-Based Compensation

 

 

1,278,000

 

 

 

1,246,000

 

Operating lease right-of-use liabilities

 

 

180,000

 

 

 

212,000

 

Net operating losses

 

 

6,100,000

 

 

 

5,568,000

 

Valuation Allowance

 

 

(8,678,000)

 

 

(7,539,000)

Deferred Tax Assets

 

 

235,000

 

 

 

322,000

 

 

 

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Operating lease right-of-use assets

 

 

(158,000)

 

 

(189,000)

Property and Equipment

 

 

(77,000)

 

 

(133,000)

 

 

 

(235,000)

 

 

(322,000)

 

 

 

 

 

 

 

 

 

Net Deferred Tax Assets and Liabilities

 

$-

 

 

$-